ArticleJournal of translational medicine2020

Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a.

Chuan-Jue Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.